A whole-genome sequencing study of 20,366 people has found that individuals with autism-associated intellectual disability carry a higher number of new mutations in the DNA regions that control gene activity in glutamatergic neurons—brain cells responsible for excitatory signaling. The findings, published open access in Genome Medicine on October 24, 2026, suggest that the non-coding majority of the human genome plays a significant role in intellectual disability. The research team, headed by Eric A. Sosa and John M. Greally with collaborators including Cathal Seoighe and Melissa J. Fazzari, examined data identifying 709,222 de novo variants—mutations absent in parents but present in offspring.
The researchers compared how these variants were distributed in people with autism and intellectual disability versus neurotypical participants. They initially observed that de novo variants clustered at cis-regulatory elements—regions controlling gene transcription—across all body cell types, regardless of whether individuals were neurodivergent or neurotypical. The disease-specific pattern emerged when they examined variant locations relative to genes: in neurodivergent individuals, both those with and without intellectual disability, de novo variants clustered at promoter-proximal cis-regulatory elements of brain cells, particularly at genes already linked to autism and intellectual disability. However, the general characteristics of these variants alone weren't distinctive enough to explain why some people developed autism or intellectual disability while others didn't. A multivariate category-wide association study then revealed enrichment of de novo variants in cis-regulatory elements of glutamatergic neurons specifically in individuals with intellectual disability, a pattern confirmed by Random Forest machine-learning analysis showing an increased burden of these events within the intellectual disability subgroup.
The authors conclude that their findings support a model where non-coding variants contribute to the oligogenic heritability of intellectual disability—meaning many genes, each with potentially small effects, collectively shape the trait—through their influence on transcriptional regulation of glutamatergic neurons. The study addresses what the report describes as a long-standing gap: although autism is strongly heritable and many genes have been implicated in causing it, the ability to make a clinical diagnosis in an affected individual remains limited. As with any observational genomic association study, the results describe enrichments and burdens at the group level, identifying a statistical pattern in variant distributions rather than establishing how any individual mutation causes disease.
The report's analysis suggests these findings help explain why intellectual disability develops in some autistic individuals but not others. By pinpointing glutamatergic neurons—cells that use glutamate as their primary excitatory neurotransmitter—the research narrows the biological mechanism to a specific brain cell type and its gene regulation. Cis-regulatory elements act like control switches for genes, determining when, where, and how much a gene is turned on. When mutations accumulate in these switches for glutamatergic neurons, the report implies, they can disrupt the precise transcriptional control needed for normal brain development and function. This oligogenic model differs from simpler genetic patterns: instead of a single gene causing the condition, many small genetic changes across multiple genes collectively push an individual toward intellectual disability.
The study points to the non-coding genome—the roughly 98% of DNA that doesn't directly code for proteins—as a meaningful contributor to neurodevelopmental conditions. Because autism is strongly heritable yet clinical diagnosis remains difficult to achieve through genetic testing alone, the report suggests that examining non-coding regulatory variants in specific brain cell types may eventually improve diagnostic capabilities. The findings highlight that understanding intellectual disability in autism requires looking beyond protein-coding genes to the regulatory machinery that controls them, particularly in the neurons most critical for brain signaling. For researchers and clinicians, the takeaway is clear: the regulatory landscape of glutamatergic neurons holds clues to why intellectual disability accompanies autism in some cases but not others.